Identification of a new CRMP5 isoform present in the nucleus of cancer cells and enhancing their proliferation

Experimental Cell Research

Volumn 319, Issue 5, 2013, Pages 588-599

  Brot, Sébastien ^a,b   Malleval, Céline ^a,b   Benetollo, Claire ^a   Auger, Carole ^a,b   Meyronet, David ^a,c   Rogemond, Véronique ^d   Honnorat, JérÔme ^a,b,d   Moradi Améli, Mahnaz ^a,b  

^a LYON NEUROSCIENCE RESEARCH CENTER   (France)

^b UNIVERSITÉ LYON 1   (France)

^c HOSPICES CIVILS DE LYON   (France)

^d HÔPITAL NEUROLOGIQUE   (France)

Author keywords

Cancer cells; Cell proliferation; Collapsin response mediator protein; CRMP5; Glioblastoma; Nuclear targeting

Indexed keywords

COLLAPSIN RESPONSE MEDIATOR PROTEIN; COLLAPSIN RESPONSE MEDIATOR PROTEIN 5; TUBULIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN DEVELOPMENT; CANCER CELL CULTURE; CELL NUCLEUS; CELL PROLIFERATION; CONTROLLED STUDY; CYTOSOL; GLIOBLASTOMA; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION;

EID: 84873992460     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2012.12.011     Document Type: Article

References (29)

1. Goshima Y., Nakamura F., Strittmatter P., Strittmatter S.M. Collapsin-induced growth cone collapse mediated by an intracellular protein related to UNC-33. Nature 1995, 376:509-514.
2. Arimura N., Kaibuchi K. Neuronal polarity: from extracellular signals to intracellular mechanisms. Nat. Rev. Neurosci. 2007, 8:194-205.
3. Fukada M., Watakabe I., Yuasa-Kawada J., Kawachi H., Kuroiwa A., Matsuda Y., Noda M. Molecular characterization of CRMP5, a novel member of the collapsin response mediator protein family. J. Biol. Chem. 2000, 275:37957-37965.
4. Inatome R., Tsujimura T., Hitomi T., Mitsui N., Hermann P., Kuroda S., Yamamura H., Yanagi S. Identification of CRAM, a novel unc-33 gene family protein that associates with CRMP3 and protein-tyrosine kinase(s) in the developing rat brain. J. Biol. Chem. 2000, 275:27291-27302.
5. Ricard D., Rogemond V., Charrier E., Aguera M., Bagnard D., Belin M.F., Thomasset N., Honnorat J. Isolation and expression pattern of human Unc-33-like phosphoprotein 6/collapsin response mediator protein 5 (Ulip6/CRMP5): coexistence with Ulip2/CRMP2 in Sema3a-sensitive oligodendrocytes. J. Neurosci 2001, 22:7203-7214.
6. Veyrac A., Giannetti N., Charrier E., Reymond-Marron I., Aguera M., Rogemond V., Honnorat J., Jourdan F. Expression of collapsin mediator proteins 1, 2 and 5 is differentially regulated in newly generated and mature neurons of the adult olfactory system. Eur. J. Neurosci. 2005, 21:2635-2648.
7. Bretin S., Reibel S., Charrier E., Maus-Moatti M., Auvergnon N., Thevenoux A., Glowinski J., Rogemond V., Honnorat J., Gauchy C. Differential expression of CRMP1, CRMP2A, CRMP2B, and CRMP5 in axons or dendrites of distinct neurons in the mouse brain. J. Comp. Neurol. 2005, 486:1-17.
8. Mitsui N., Inatome R., Takahashi S., Goshima Y., Yamamura H., Yanagi S. Involvement of Fes/Fps tyrosine kinase in semaphorin 3A signaling. EMBO J. 2002, 21:3274-3285.
9. Takahashi S., Inatome R., Yamamura H., Yanagi S. Isolation and expression of a novel mitochondrial septin that interacts with CRMP/CRAM in the developing neurones. Genes Cells 2003, 8:81-93.
10. Hotta A., Inatome R., Yuasa-Kawada J., Qin Q., Yamamura H., Yanagi S. Critical role of collapsin response mediator protein-associated molecule CRAM for filopodia and growth cone development in neurons. Mol. Biol. Cell 2005, 16:32-39.
11. Brot S., Rogemond V., Perrot V., Chounlamountri N., Auger C., Honnorat J., Moradi-Améli M. CRMP5 interacts with tubulin to inhibit neurite outgrowth, thereby modulating the function of CRMP2. J. Neurosci. 2010, 30:10639-10654.
12. Honnorat J., Antoine J.C., Derrington E., Aguera M., Belin M.F. Antibodies to a subpopulation of glial cells and a 66kDa developmental protein in patients with paraneoplastic neurological syndromes. J. Neurol. Neurosurg. Psychiatry 1996, 61:270-278.
13. Honnorat J., Cartalat-Carel S., Ricard D., Camdessanche J.P., Carpentier A.F., Rogemond V., Chapuis F., Aguera M., Decullier E., Graus A.M., Antoine J.C. Onco-neural antibodies and tumor type determine survival and neurological symptoms in paraneoplastic neurological syndromes with Hu or CV2/CRMP5 antibodies. J. Neurol. Neurosurg. Psychiatry 2009, 80:412-416.
14. Meyronet D., Massoma P., Thivolet F., Chalabreysse L., Rogemond V., Schlama A., Honnorat J., Thomasset N. Extensive expression of collapsin response mediator protein 5 (CRMP5) is a specific marker of high-grade lung neuroendocrine carcinoma. Am. J. Surg. Pathol. 2008, 32:1699-1708.
15. Liang Y., Diehn M., Watson N., Bollen A.W., Aldape K.D., Nicholas M.K., Lamborn K.R., Berger M.S., Botstein D., Brown P.O., Israel M.A. Gene expression profiling reveals molecularly and clinically distinct subtypes of glioblastoma multiforme. Proc. Natl. Acad. Sci. USA 2005, 102:5814-5819.
16. Rogemond V., Auger C., Giraudon P., Becchi M., Auvergnon N., Belin M.F., Honnorat J., Moradi-Améli M. Processing and nuclear localization of CRMP2 during brain development induce neurite outgrowth inhibition. J. Biol. Chem. 2008, 283:14751-14761.
17. Fukata Y., Itoh T.J., Kimura T., Menager C., Nishimura T., Shiromizu T., Watanabe H., Inagaki N., Iwamatsu A., Hotani H., Kaibuchi K. CRMP-2 binds to tubulin heterodimers to promote microtubule assembly. Nat. Cell Biol. 2002, 4:583-591.
18. Honnorat J., Byk T., Kusters I., Aguera M., Ricard D., Rogemond V., Quach T., Aunis D., Sobel A., Mattei M.G., Kolattukudy P., Belin M.F., Antoine J.C. Ulip/CRMP proteins are recognized by autoantibodies in paraneoplastic neurological syndromes. Eur. J. Neurosci. 1999, 11:4226-4232.
19. Monstad S.E., Drivsholm L., Skeie G.O., Aarseth J.H., Vedeler C.A. CRMP5 antibodies in patients with small-cell lung cancer or thymoma. Cancer Immunol. Immunother. 2008, 57:227-232.
20. Hou S.T., Jiang S.X., Desbois A., Huang D., Kelly J., Tessier L., Karchewski L., Kappler J. Calpain-cleaved collapsin response mediator protein-3 induces neuronal death after glutamate toxicity and cerebral ischemia. J. Neurosci. 2006, 26:2241-2249.
21. Aylsworth A., Jiang S.X., Desbois A., Hou S.T. Characterization of the role of full-length CRMP3 and its calpain-cleaved product in inhibiting microtubule polymerization and neurite outgrowth. Exp. Cell Res. 2009, 315:2856-2868.
22. Tahimic C.G., Tomimatsu N., Nishigaki R., Fukuhara A., Toda T., Kaibuchi K., Shiota G., Oshimura M., Kurimasa A. Evidence for a role of collapsin response mediator protein-2 in signaling pathways that regulate the proliferation of non-neuronal cells. Biochem. Biophys. Res. Commun. 2006, 340:1244-1250.
23. Weis K. Nucleocytoplasmic transport: cargo trafficking across the border. Curr. Opin. Cell Biol. 2002, 14:328-335.
24. Bretin S., Rogemond V., Marin P., Maus M., Torrens Y., Honnorat J., Glowinski J., Prémont J., Gauchy C. Calpain product of WT-CRMP2 reduces the amount of surface NR2B NMDA receptor subunit. J. Neurochem. 2006, 98:1252-1265.
25. Jiang S.X., Kappler J., Zurakowski B., Desbois A., Aylsworth A., Hou S.T. Calpain cleavage of collapsin response mediator proteins in ischemic mouse brain. Eur. J. Neurosci. 2007, 26:801-809.
26. Zhang Z., Ottens A.K., Sadasivan S., Kobeissy F.H., Fang T., Hayes R.L., Wang K.K. Calpain-mediated collapsin response mediator protein-1, -2, and -4 proteolysis after neurotoxic and traumatic brain injury. J. Neurotrauma 2007, 24:460-472.
27. Yamashita N., Mosinger B., Roy A., Miyazaki M., Ugajin K., Nakamura F., Sasaki Y., Yamaguchi K., Kolattukudy P., Goshima Y. CRMP5 (Collapsin Response Mediator Protein 5) regulates dendritic development and synaptic plasticity in the cerebellar purkinje cells. J. Neurosci. 2011, 31:1773-1779.
28. Quach T.T., Duchemin A.M., Rogemond V., Aguera M., Honnorat J., Belin M.F., Kolattukudy P.E. Involvement of collapsin response mediator proteins in the neurite extension induced by neurotrophins in dorsal root. Mol. Cell Neurosci. 2004, 25:433-443.
29. Krüttgen A., Schneider I., Weis J. The dark side of the NGF family: neurotrophins in neoplasias. Brain Pathol 2006, 16:304-310.